TickerFactsScreenerDevelopers

BIOMARIN PHARMACEUTICAL INC (BMRN) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2008: $56.37M2009: $89.80M2010: $49.46M2011: $73.22M2012: $44.57M2013: $65.19M2014: $117.06M2015: $227.65M2016: $148.38M2017: $199.22M2018: $144.62M2019: $145.03M2020: $114.31M2021: $95.58M2022: $120.96M2023: $96.69M2024: $85.42M2025: $103.04M$103.04M
2008Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$103.04M+20.6%
2024$85.42M-11.7%
2023$96.69M-20.1%
2022$120.96M+26.6%
2021$95.58M-16.4%
2020$114.31M-21.2%
2019$145.03M+0.3%
2018$144.62M-27.4%
2017$199.22M+34.3%
2016$148.38M-34.8%
2015$227.65M+94.5%
2014$117.06M+79.6%
2013$65.19M+46.3%
2012$44.57M-39.1%
2011$73.22M+48.0%
2010$49.46M-44.9%
2009$89.80M+59.3%
2008$56.37M—